Skip to main content
Top
Published in: AIDS and Behavior 1/2019

01-01-2019 | Original Paper

Characteristics of Out-of-Care Patients Who Required a Referral for Re-engagement Services by Public Health Bridge Counselors Following a Brief Clinic-Based Retention Intervention

Authors: Nada Fadul, Sarah J. Willis, Jenna Donovan, Aimee Wilkin, Amy Durr Heine, Anna LeViere, Ciarra Dortche, Evelyn Byrd Quinlivan

Published in: AIDS and Behavior | Special Issue 1/2019

Login to get access

Abstract

The NC-LINK Project initiated both clinic-based retention services and state public health bridge counselor-based (SBCs) re-engagement services to retain and re-engage people living with HIV infection (PLWH) in care. The goal of this project is to compare efforts between clinic-based retention and SBC re-engagement services to determine whether patients are more or less likely to remain in HIV care services. Clinic appointment data were used to identify patients who were last seen more than 6–9 months prior. Patients either received clinic-based retention services only or were subsequently referred to the SBC re-engagement intervention if the retention services were unsuccessful. The frequency of re-engagement in care (180 days) and HIV suppression (VLS, within 1 year) was examined for patients in these two groups. The SBC group was less likely to have VLS at the visit prior to referral (adjusted OR 2.04, 95% CI 1.53, 2.72). Patients who were referred to the SBC were less likely to re-engage in care within 180 days as compared to those who received clinic-based retention services only (adjusted OR 0.29, 95% CI 0.21, 0.41).
Literature
1.
go back to reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRefPubMedPubMedCentral Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRefPubMedPubMedCentral
2.
go back to reference Dombrowski JC, Kitahata MM, Van Rompaey SE, Crane HM, Mugavero MJ, Eron JJ, et al. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. J Acquir Immune Defic Syndr. 2013;63(3):299–306.CrossRefPubMedPubMedCentral Dombrowski JC, Kitahata MM, Van Rompaey SE, Crane HM, Mugavero MJ, Eron JJ, et al. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. J Acquir Immune Defic Syndr. 2013;63(3):299–306.CrossRefPubMedPubMedCentral
3.
go back to reference Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301(22):2380–2.CrossRefPubMed Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301(22):2380–2.CrossRefPubMed
4.
go back to reference Mugavero MJ, Amico KR, Westfall AO, Crane HM, Zinski A, Willig JH, et al. Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J Acquir Immune Defic Syndr. 2012;59(1):86–93.CrossRefPubMedPubMedCentral Mugavero MJ, Amico KR, Westfall AO, Crane HM, Zinski A, Willig JH, et al. Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J Acquir Immune Defic Syndr. 2012;59(1):86–93.CrossRefPubMedPubMedCentral
5.
go back to reference Shah M, Risher K, Berry SA, Dowdy DW. The epidemiologic and economic impact of improving HIV testing, linkage, and retention in care in the United States. Clin Infect Dis. 2016;62(2):220–9.CrossRefPubMed Shah M, Risher K, Berry SA, Dowdy DW. The epidemiologic and economic impact of improving HIV testing, linkage, and retention in care in the United States. Clin Infect Dis. 2016;62(2):220–9.CrossRefPubMed
6.
go back to reference Giordano TP. Retention in HIV care: what the clinician needs to know. Top Antivir Med. 2011;19(1):12–6.PubMed Giordano TP. Retention in HIV care: what the clinician needs to know. Top Antivir Med. 2011;19(1):12–6.PubMed
7.
go back to reference Mugavero MJ, Westfall AO, Cole SR, Geng EH, Crane HM, Kitahata MM, et al. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis. 2014;59(10):1471–9.CrossRefPubMedPubMedCentral Mugavero MJ, Westfall AO, Cole SR, Geng EH, Crane HM, Kitahata MM, et al. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis. 2014;59(10):1471–9.CrossRefPubMedPubMedCentral
8.
go back to reference Tripathi A, Youmans E, Gibson JJ, Duffus WA. The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study. AIDS Res Hum Retroviruses. 2011;27(7):751–8.CrossRefPubMed Tripathi A, Youmans E, Gibson JJ, Duffus WA. The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study. AIDS Res Hum Retroviruses. 2011;27(7):751–8.CrossRefPubMed
10.
go back to reference Williams B, Amico KR, Konkle-Parker D. Qualitative to assessment of barriers and facilitators to HIV treatment. J Assoc Nurses AIDS Care. 2011;22(4):307–12.CrossRefPubMedPubMedCentral Williams B, Amico KR, Konkle-Parker D. Qualitative to assessment of barriers and facilitators to HIV treatment. J Assoc Nurses AIDS Care. 2011;22(4):307–12.CrossRefPubMedPubMedCentral
11.
go back to reference Whetten K, Leserman J, Whetten R, Ostermann J, Thielman N, Swartz M, et al. Exploring lack of trust in care providers and the government as a barrier to health service use. Am J Public Health. 2006;96(4):716–21.CrossRefPubMedPubMedCentral Whetten K, Leserman J, Whetten R, Ostermann J, Thielman N, Swartz M, et al. Exploring lack of trust in care providers and the government as a barrier to health service use. Am J Public Health. 2006;96(4):716–21.CrossRefPubMedPubMedCentral
12.
go back to reference Berger MB, Sullivan KA, Parnell HE, Keller J, Pollard A, Cox ME, et al. Barriers and facilitators to retaining and reengaging HIV clients in care: a case study of North Carolina. J Int Assoc Provid AIDS Care. 2015;15:486–93.CrossRefPubMed Berger MB, Sullivan KA, Parnell HE, Keller J, Pollard A, Cox ME, et al. Barriers and facilitators to retaining and reengaging HIV clients in care: a case study of North Carolina. J Int Assoc Provid AIDS Care. 2015;15:486–93.CrossRefPubMed
13.
go back to reference Reif SS, Whetten K, Wilson ER, McAllaster C, Pence BW, Legrand S, et al. HIV/AIDS in the Southern USA: a disproportionate epidemic. AIDS Care. 2014;26(3):351–9.CrossRefPubMed Reif SS, Whetten K, Wilson ER, McAllaster C, Pence BW, Legrand S, et al. HIV/AIDS in the Southern USA: a disproportionate epidemic. AIDS Care. 2014;26(3):351–9.CrossRefPubMed
16.
go back to reference Swygard H, Sena AC, Mobley V, Clymore J, Sampson LA, Glenn K, et al. Implementation of a statewide team to facilitate linkage and re-engagement in HIV care in North Carolina. N C Med J. 2016 (In press). Swygard H, Sena AC, Mobley V, Clymore J, Sampson LA, Glenn K, et al. Implementation of a statewide team to facilitate linkage and re-engagement in HIV care in North Carolina. N C Med J. 2016 (In press).
19.
go back to reference Milberg JA. Development, use, and integration of a nationally-distributed HIV/AIDS electronic health information system. J Am Med Inform Assoc. 2016;23:1190–4.CrossRefPubMed Milberg JA. Development, use, and integration of a nationally-distributed HIV/AIDS electronic health information system. J Am Med Inform Assoc. 2016;23:1190–4.CrossRefPubMed
20.
go back to reference Firth CL, Schafer SD, Greene K. Monitoring retention in care: using multiple laboratory tests as an indicator for HIV medical care. AIDS Care. 2014;26(12):1546–9.CrossRefPubMed Firth CL, Schafer SD, Greene K. Monitoring retention in care: using multiple laboratory tests as an indicator for HIV medical care. AIDS Care. 2014;26(12):1546–9.CrossRefPubMed
21.
go back to reference Muthulingam D, Chin J, Hsu L, Scheer S, Schwarcz S. Disparities in engagement in care and viral suppression among persons with HIV. J Acquir Immune Defic Syndr. 2013;63(1):112–9.CrossRefPubMed Muthulingam D, Chin J, Hsu L, Scheer S, Schwarcz S. Disparities in engagement in care and viral suppression among persons with HIV. J Acquir Immune Defic Syndr. 2013;63(1):112–9.CrossRefPubMed
22.
go back to reference Eaton EF, Saag MS, Mugavero M. Engagement in human immunodeficiency virus care: linkage, retention, and antiretroviral therapy adherence. Infect Dis Clin N Am. 2014;28(3):355–69.CrossRef Eaton EF, Saag MS, Mugavero M. Engagement in human immunodeficiency virus care: linkage, retention, and antiretroviral therapy adherence. Infect Dis Clin N Am. 2014;28(3):355–69.CrossRef
Metadata
Title
Characteristics of Out-of-Care Patients Who Required a Referral for Re-engagement Services by Public Health Bridge Counselors Following a Brief Clinic-Based Retention Intervention
Authors
Nada Fadul
Sarah J. Willis
Jenna Donovan
Aimee Wilkin
Amy Durr Heine
Anna LeViere
Ciarra Dortche
Evelyn Byrd Quinlivan
Publication date
01-01-2019
Publisher
Springer US
Published in
AIDS and Behavior / Issue Special Issue 1/2019
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2110-9

Other articles of this Special Issue 1/2019

AIDS and Behavior 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.